Mutual of America Capital Management’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Mutual of America Capital Management’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-81,624	Closed	-$2.21M	–	1706
2019 Q2	$2.21M	Buy	81,624 +53	+0.1%	+$1.66K	0.03%	833
2019 Q1	$2.83M	Buy	81,571 +1,480	+2%	+$42.7K	0.04%	691
2018 Q4	$1.56M	Hold	80,091	–	–	0.03%	912
2018 Q3	$2.13M	Buy	80,091 +27,516	+52%	+$898K	0.03%	873
2018 Q2	$1.99M	Buy	+52,575	New	+$2.01M	0.03%	886

Other funds holding PTLA

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return

Mutual of America Capital Management's PTLA Position: Q3 2019 in Review

Mutual of America Capital Management sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2019, closing a stake of 81,624 shares — an estimated $2.21M sold.

Mutual of America Capital Management first reported a position in PTLA in Q2 2018 and held it in 5 quarters. The position peaked at $2.83M in Q1 2019. 212 funds tracked by Wall St. Rank hold PTLA as of Q3 2019.

Mutual of America Capital Management reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2019 after selling out during the quarter.
Mutual of America Capital Management sold 81,624 Portola Pharmaceuticals, Inc. shares in Q3 2019, an estimated $2.21M.
Mutual of America Capital Management first reported a position in Portola Pharmaceuticals, Inc. in Q2 2018 and held it in 5 quarters.
Mutual of America Capital Management's Portola Pharmaceuticals, Inc. position peaked at $2.83M in Q1 2019.
212 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2019.

Based on Mutual of America Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.